HUP0203097A2 - Phospholipid gel - Google Patents

Phospholipid gel

Info

Publication number
HUP0203097A2
HUP0203097A2 HU0203097A HUP0203097A HUP0203097A2 HU P0203097 A2 HUP0203097 A2 HU P0203097A2 HU 0203097 A HU0203097 A HU 0203097A HU P0203097 A HUP0203097 A HU P0203097A HU P0203097 A2 HUP0203097 A2 HU P0203097A2
Authority
HU
Hungary
Prior art keywords
weight
phospholipid gel
phospholipid
gel
valent
Prior art date
Application number
HU0203097A
Other languages
Hungarian (hu)
Inventor
Ruland Fridrich
Bernd Ibscher
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of HUP0203097A2 publication Critical patent/HUP0203097A2/en
Publication of HUP0203097A3 publication Critical patent/HUP0203097A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0052—Preparation of gels
    • B01J13/0065—Preparation of gels containing an organic phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány egy foszfolipidgélre vonatkozik, amely - 5-60 tömeg%-ban legalább egy foszfolipidet; - legalább 1 tömeg%-ban legalább egy 2- vagy 3- értékű C2-4-alkoholt; - 0,5-35 tömeg-banlegalább egy 4-, 5- vagy 6- értékű alkoholt és/vagy legalább egycukrot; és - adott esetben egy vagy több adalékanyagot és 100 tömeg%-ra kiegészítő mennyiségben vizet tartalmaz, A találmány vonatkozik afoszfolipidgélt tartalmazó koztmetikai és gyógyászati készítményekre,a foszfolipoidgél alkalmazására, valamint annak előállítására is. ÓThe invention relates to a phospholipid gel which - 5-60% by weight of at least one phospholipid; - at least 1% by weight of at least one 2- or 3-valent C2-4 alcohol; - 0.5-35% by weight of at least one 4-, 5- or 6-valent alcohol and/or at least one sugar; and - optionally contains one or more additives and 100% by weight of additional water. The invention applies to cosmetic and medicinal preparations containing phospholipid gel, to the use of phospholipid gel, as well as to its production. HE

HU0203097A 1999-08-25 2000-08-16 Phospholipid gel HUP0203097A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19940227A DE19940227A1 (en) 1999-08-25 1999-08-25 Phospholipid gel
PCT/EP2000/007993 WO2001013887A2 (en) 1999-08-25 2000-08-16 Phospholipin gel

Publications (2)

Publication Number Publication Date
HUP0203097A2 true HUP0203097A2 (en) 2003-01-28
HUP0203097A3 HUP0203097A3 (en) 2006-11-28

Family

ID=7919498

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203097A HUP0203097A3 (en) 1999-08-25 2000-08-16 Phospholipid gel

Country Status (13)

Country Link
EP (1) EP1206245A2 (en)
JP (1) JP2003507408A (en)
AU (1) AU776766B2 (en)
CA (1) CA2381571A1 (en)
CZ (1) CZ2002561A3 (en)
DE (1) DE19940227A1 (en)
HU (1) HUP0203097A3 (en)
NO (1) NO20020768D0 (en)
PL (1) PL353215A1 (en)
RU (1) RU2261088C2 (en)
SK (1) SK2442002A3 (en)
WO (1) WO2001013887A2 (en)
ZA (1) ZA200201506B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1230917A1 (en) * 2001-02-08 2002-08-14 Vectron Therapeutics AG Invasomes for the therapy of illnesses, their manufacture and use
CN1335182A (en) * 2001-08-08 2002-02-13 华中科技大学 Insulin spray for oral cavity and its prepn process
DE10255285A1 (en) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Self-forming phospholipid gels
DE10255195A1 (en) * 2002-11-27 2004-06-09 Lipoid Gmbh Micellar water-soluble concentrates
AU2003301174A1 (en) * 2002-12-20 2004-07-22 Idexx Laboratories, Inc. Liposomal analgesic formulation and use
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
FI20065222L (en) * 2006-04-05 2007-10-06 Finnfeeds Finland Oy Use of inositol
ITMI20081862A1 (en) * 2008-10-21 2010-04-22 Funziona Srl COMPOSITION FOR TOPIC USE FOR THE TREATMENT OF LOCALIZED ADIPOSITIES AND RELATED IMAGINATIONS
EP2355803A4 (en) * 2008-11-14 2012-04-25 Archer Daniels Midland Co Organogel compositions and processes for producing
EP2210589B1 (en) * 2009-01-22 2015-05-06 Ludwig-Maximilians-Universität München Vesicular phospholipid gels comprising proteinaceous substances
BE1018506A3 (en) * 2009-02-26 2011-02-01 Bogaert Gina Van COMPOSITION OF A HYDROCORTISONE, ITS DERIVATIVES, METABOLITES, PRODRUGS OR MIXTURES, LIPOSOMAL GEL AND ITS USE.
JP5901617B2 (en) 2010-05-14 2016-04-13 アーチャー−ダニエルズ−ミッドランド カンパニー Food composition containing organogel
JP2017214299A (en) * 2016-05-30 2017-12-07 ライオン株式会社 Semisolid formulation and method for producing the same
IL269579B1 (en) 2017-03-23 2024-02-01 Lipid Systems Sp Z O O High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3585967D1 (en) * 1984-03-08 1992-06-11 Phares Pharma Holland LIPOSOME FORMING COMPOSITION.
JP2501336B2 (en) * 1987-07-02 1996-05-29 第一製薬株式会社 Stable liposomal formulation
WO1990012565A1 (en) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Water-containing formulations with phospholipids
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
DE4003783C2 (en) * 1990-02-08 1999-03-25 Nattermann A & Cie Phospholipid-containing gel, process for its preparation and use
DE4021082C2 (en) * 1990-07-03 1995-08-17 Hans Dr Lautenschlaeger High lipid-containing skin treatment agent using a bilayer-containing system, organic acid salts, alcohol and stabilizer
DE19520659A1 (en) * 1995-06-09 1996-12-12 Mika Pharma Ges Fuer Die Entwi Compsn. to treat virus infections of skin etc
DE19719604A1 (en) * 1997-05-09 1998-07-16 Henkel Kgaa Hair dye, for human hair, that are easier to formulate and apply

Also Published As

Publication number Publication date
WO2001013887A2 (en) 2001-03-01
AU776766B2 (en) 2004-09-23
WO2001013887A3 (en) 2001-09-20
NO20020768L (en) 2002-02-15
CA2381571A1 (en) 2001-03-01
EP1206245A2 (en) 2002-05-22
PL353215A1 (en) 2003-11-03
DE19940227A1 (en) 2001-03-08
SK2442002A3 (en) 2002-08-06
AU7276700A (en) 2001-03-19
CZ2002561A3 (en) 2002-07-17
HUP0203097A3 (en) 2006-11-28
ZA200201506B (en) 2003-05-28
NO20020768D0 (en) 2002-02-15
JP2003507408A (en) 2003-02-25
RU2261088C2 (en) 2005-09-27

Similar Documents

Publication Publication Date Title
HUP0203097A2 (en) Phospholipid gel
HUP9800688A2 (en) Complex of gamma-cyclodextrin and retinol or retinol derivatives, process for their production and cosmetic an pharmaceutical compositions containing them
HUP0302881A2 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
HUP0400689A2 (en) Abca-1 level elevating compounds
HUP0303854A2 (en) Synthetic erythropoiesis stimulating proteins
HUP0303996A2 (en) Vaccine composition
DE60110342T8 (en) Alpha-interferon-containing skin care products
HUP0100562A2 (en) Spheroids method for their preparation and pharmaceutical compositions containing them
HUP0301941A2 (en) Composition containing combined sea animal and plant extract compounds
MXPA03010630A (en) Novel pyrrole derivatives as pharmaceutical agents.
NO962187D0 (en) Compositions that inhibit apoptosis, methods of purifying the compositions and their use
AU516058B2 (en) Production of titanium or zirconium by plasma reduction
HUP0302474A2 (en) Therapeutically effective tropane derivatives, process for their preparation pharmaceutical compositions containing them and their use
NO306930B1 (en) Use of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole (Pramipexole) as an antidepressant
HUP0301391A2 (en) Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use
HUP0302585A2 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions
NO944448D0 (en) New pharmaceutical applications of krill enzymes
HUP0001014A2 (en) Use of gastrointestinal lipase inhibitors
GR1002555B (en) Skin care compositions
HUP9903935A2 (en) Pharmaceutical compositions with vitamin d analogues
HUP9700826A1 (en) Pharmaceutical compositions against peptic ulcer
HUP9801387A2 (en) Antibacterial cephalosporins
CA2323239A1 (en) Novel matrix metalloproteinase inhibitors and down-regulators
WO2005018342A8 (en) Compositions and methods for the maintenance of oral health
HUP0202803A2 (en) Titanium derived compounds, preparation and use thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees